InvestorsHub Logo
Followers 3
Posts 175
Boards Moderated 0
Alias Born 01/30/2013

Re: None

Tuesday, 12/24/2013 5:58:40 AM

Tuesday, December 24, 2013 5:58:40 AM

Post# of 15800
My gut impression/ and I moved to the sidelines, with that announcement basically said, if you read between the lines, and I was not the only one taking this stance by Tesaro's haircut in share price, that' Rolapitant is "NO" slamdunk with the FDA. They said they will still proceed in approval, "BUT" and that's a big word that nobody likes, they missed on one entity going forward that could be a stumbling block that might lead to further testing/delays or an outright no by the FDA.
Uncertainty in the drug adoption business is what drives investors nuts and this is no exception . My guess is if it get ok'ed next Q., you'll see both stocks tack on goodly gains, but temporarily it just adds to a shroud of uncertainty and hence the skittishness in its investors.OPKO's road sure isn't void of potholes! lol good luck all.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News